Tourmaline Bio (TRML) Short Interest Ratio & Short Volume → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free TRML Stock Alerts $15.68 -0.32 (-2.00%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Tourmaline Bio Short Interest DataCurrent Short Volume1,790,000 sharesPrevious Short Volume1,480,000 sharesChange Vs. Previous Month+20.95%Dollar Volume Sold Short$33.99 millionShort Interest Ratio / Days to Cover4.1Last Record DateApril 15, 2024Outstanding Shares25,650,000 sharesFloat Size15,460,000 sharesShort Percent of Float11.58%Today's Trading Volume360,260 sharesAverage Trading Volume433,350 sharesToday's Volume Vs. Average83% Short Selling Tourmaline Bio ? Sign up to receive the latest short interest report for Tourmaline Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTRML Short Interest Over TimeTRML Days to Cover Over TimeTRML Percentage of Float Shorted Over Time Ad DTIIf you have $2,500 bucks… check this out This computer whiz has been averaging 234% per year with an undefeated strategy he calls… The “Income Glitch” And he’s been making out like a bandit with a 100% success rate on over 64 trade opportunities! Click here to unlock the Income Glitch training workshop for free. Tourmaline Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,790,000 shares $33.99 million +21.0%11.6%4.1 $18.99 3/31/20241,480,000 shares $33.89 million +123.1%9.6%4.1 $22.90 3/15/2024663,500 shares $28.66 million -14.9%4.3%2 $43.19 2/29/2024779,800 shares $30.27 million +14.0%5.1%3.5 $38.82 2/15/2024684,000 shares $26.95 million +47.6%4.4%3.4 $39.40 1/31/2024463,500 shares $15.48 million No Change2.9%2.8 $33.39 TRML Short Interest - Frequently Asked Questions What is Tourmaline Bio's current short interest? Short interest is the volume of Tourmaline Bio shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,790,000 shares of TRML short. 11.58% of Tourmaline Bio's shares are currently sold short. Learn More on Tourmaline Bio's current short interest. What is a good short interest ratio for Tourmaline Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TRML shares currently have a short interest ratio of 4.0. Learn More on Tourmaline Bio's short interest ratio. What is a good short interest percentage for Tourmaline Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.58% of Tourmaline Bio's floating shares are currently sold short. Is Tourmaline Bio's short interest increasing or decreasing? Tourmaline Bio saw a increase in short interest in April. As of April 15th, there was short interest totaling 1,790,000 shares, an increase of 20.9% from the previous total of 1,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tourmaline Bio's float size? Tourmaline Bio currently has issued a total of 25,650,000 shares. Some of Tourmaline Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tourmaline Bio currently has a public float of 15,460,000 shares. How does Tourmaline Bio's short interest compare to its competitors? 11.58% of Tourmaline Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Tourmaline Bio: Replimune Group, Inc. (18.75%), Lexeo Therapeutics, Inc. (5.21%), Voyager Therapeutics, Inc. (6.37%), iTeos Therapeutics, Inc. (7.43%), Taysha Gene Therapies, Inc. (8.59%), Aura Biosciences, Inc. (6.50%), Humacyte, Inc. (4.38%), Adaptive Biotechnologies Co. (7.23%), Caribou Biosciences, Inc. (14.24%), Editas Medicine, Inc. (22.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Tourmaline Bio stock? Short selling TRML is an investing strategy that aims to generate trading profit from Tourmaline Bio as its price is falling. TRML shares are trading down $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tourmaline Bio? A short squeeze for Tourmaline Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TRML, which in turn drives the price of the stock up even further. How often is Tourmaline Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRML, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: REPL Short Squeeze LXEO Short Squeeze VYGR Short Squeeze ITOS Short Squeeze TSHA Short Squeeze AURA Short Squeeze HUMA Short Squeeze ADPT Short Squeeze CRBU Short Squeeze EDIT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRML) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithProtect Your Bank Account Before It’s Too LateWeiss RatingsBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets